Monica de Baca, MD

VP Medical Affairs, Sysmex-America, Inc., Sysmex America, Inc.

Dr de Baca is a board-certified anatomic and clinical (AP/CP) pathologist, hematopathologist and ophthalmologist. She is the Vice President for Medical Affairs at Sysmex America, Inc., and co-founder of MD Path, LLC, a pathology consulting service.  She earned her medical degree at the Universidad del Salvador in Buenos Aires, Argentina, and completed her ophthalmology residency at Achenbach Hospital, Königs Wusterhausen and E.-v.-Bergmann Clinic in Potsdam, Germany. She completed a transitional year at Texas Tech University before receiving her AP/CP residency and hematopathology fellowship training at Thomas Jefferson University Hospitals in Philadelphia. Before joining Sysmex, Dr. de Baca has had roles as the director of Hematopathology and director of CLIA labs in private practice, academic practice and industry on the East Coast, the Plains and in the Pacific Northwest.. 

Dr. de Baca is active in numerous medical and pathology organizations, including the United States and Canadian Academy of Pathology, American Society of Hematology, Society for Hematopathology and Association of Diagnostic and Laboratory Medicine.She is a past president of the Association for Pathology Informatics and served on the Clinical Laboratory Improvement Advisory Committee (CLIAC), which reports to CDC and HHS.

Currently on the Board of Governors of the College of American Pathologists, Dr. de Baca has been an active member of several of its councils and committees; she has served as the Council on Education chair, Artificial Intelligence Committee vice chair and as a member of the Information Technology Leadership, Informatics and Diversity, Equity, Inclusion committees. She was the founding chair of the Pathology Electronic Reporting Committee and served as a member of the Cancer Committee where she co-authored several CAP Cancer Checklists. Dr. de Baca represented CAP as a liaison to SNOMED International and the North American Association of Central Cancer Registries. Dr. de Baca currently chairs the CAP’s Council on Informatics and Pathology Innovation.